About Nyxoah S.A.
https://www.nyxoah.comNyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
CEO
Olivier Taelman
Compensation Summary
(Year )
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:1.19M
Value:$6.07M
VESTAL POINT CAPITAL, LP
Shares:1.11M
Value:$5.67M
BLACKROCK, INC.
Shares:743.4K
Value:$3.81M
Summary
Showing Top 3 of 36
About Nyxoah S.A.
https://www.nyxoah.comNyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.97M ▲ | $25.56M ▲ | $-23.58M ▼ | -1.2K% ▲ | $-0.63 ▼ | $-20.86M ▼ |
| Q2-2025 | $1.34M ▲ | $20.7M ▼ | $-20.61M ▲ | -1.54K% ▲ | $-0.55 ▲ | $-19.3M ▲ |
| Q1-2025 | $1.06M ▼ | $21.3M ▲ | $-22.38M ▼ | -2.1K% ▼ | $-0.6 ▼ | $-21.2M ▼ |
| Q4-2024 | $1.26M ▼ | $19.24M ▲ | $-17.15M ▼ | -1.36K% ▼ | $-0.46 ▲ | $-14.81M ▲ |
| Q3-2024 | $1.27M | $15.76M | $-17.06M | -1.35K% | $-0.5 | $-15.88M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $22.48M ▼ | $93.6M ▼ | $42.65M ▼ | $50.95M ▼ |
| Q2-2025 | $42.99M ▼ | $116.47M ▼ | $43.07M ▲ | $73.4M ▼ |
| Q1-2025 | $63.05M ▼ | $135.9M ▼ | $43.06M ▼ | $92.84M ▼ |
| Q4-2024 | $85.56M ▲ | $158.41M ▲ | $45.15M ▲ | $113.25M ▲ |
| Q3-2024 | $70.98M | $142.76M | $38.06M | $104.71M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-23.58M ▼ | $-20.48M ▼ | $8.82M ▼ | $-305K ▲ | $-11.86M ▼ | $-20.51M ▼ |
| Q2-2025 | $-20.61M ▲ | $-16.73M ▲ | $18.66M ▲ | $-472K ▲ | $335K ▲ | $-17.28M ▲ |
| Q1-2025 | $-22.38M ▼ | $-18.52M ▼ | $8.13M ▲ | $-730K ▼ | $-11.79M ▼ | $-18.73M ▼ |
| Q4-2024 | $-15.07M ▲ | $-12.2M ▲ | $-6.58M ▼ | $23.38M ▲ | $5.51M ▲ | $-13.75M ▲ |
| Q3-2024 | $-16.88M | $-13.44M | $5.82M | $9.08M | $954K | $-14.21M |
Revenue by Geography
| Region | Q3-2022 | Q4-2022 | Q2-2023 | Q4-2023 |
|---|---|---|---|---|
 AUSTRIA | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 GERMANY | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 SWITZERLAND | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
Olivier Taelman
Compensation Summary
(Year )
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:1.19M
Value:$6.07M
VESTAL POINT CAPITAL, LP
Shares:1.11M
Value:$5.67M
BLACKROCK, INC.
Shares:743.4K
Value:$3.81M
Summary
Showing Top 3 of 36